Filing Flows › Verrica Pharmaceuticals (VRCA) › Recalls, complaints & regulation
Verrica Pharmaceuticals (VRCA): clinical trials
Verrica Pharmaceuticals (VRCA) beyond its filings: 4 active clinical trials.
Verrica Pharmaceuticals' latest quarter
Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Verrica Pharmaceuticals have?
4 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.